LOXL2 and neoplasm: Studies of mechanisms in vitro support that tumor cell-derived LOXL2 directly stimulated stromal fibroblast proliferation and activity by enhancing PDGF-AB-mediated signaling after modification of PDGFRβ, while having no proliferative effect on tumor cells themselves.